Drug Safety Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug safety communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Safety Communications Today - Breaking & Trending Today

MIL-OSI USA: Certain Type of Medicines Approved for Type 2 Diabetes and Obesity: Drug Safety Communication – Update on FDA's Ongoing Evaluation of Reports of Suicidal Thoughts or Actions

MIL-OSI USA: Certain Type of Medicines Approved for Type 2 Diabetes and Obesity: Drug Safety Communication – Update on FDA's Ongoing Evaluation of Reports of Suicidal Thoughts or Actions
foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.

Health Care Professionals , Adverse Event Reporting Program , Drug Safety Communications , Health Professional , Event Reporting System , Care Professionals , Watch Safety Information ,

Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bydureon Bcise , Drug Administration , Drug Safety Communications , Event Reporting System , Sentinel Systemexternal Link , Link Disclaimer , External Link Disclaimer ,

FDA Updates Warnings for Drugs Used to Treat Narcolepsy

For a class of drugs used for narcolepsy, the FDA is requiring updates to the Boxed Warning to address concerns of abuse and addiction.  ....

Health Care Professionals Do , Drug Safety Communications , Drug Administration , Boxed Warning , Should Health Care Professionals , Medication Guide ,

FDA issues alert over arthritis, ulcerative colitis medicine


FDA issues alert over arthritis, ulcerative colitis medicine
Trial shows increased risk of heart-related problems, cancer
Published: 
Tags: 
WASHINGTON – The U.S. Food and Drug Administration is alerting the public about an increased risk of serious heart-related problems and cancer with the arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib) compared to another type of medicine called tumor necrosis factor (TNF) inhibitors.
The FDA required the safety trial, which also investigated other potential risks, including blood clots in the lungs and death. Those final results are not yet available.
“We will evaluate the clinical trial results we have received to date and will work with the drug manufacturer to obtain further information as soon as possible,” the FDA said Thursday in a news release. “We will communicate our final conclusions and recommendations when we have completed our review or have more information to share.� ....

United States , Drug Safety Communications , Drug Administration , Boxed Warning , External Link Disclaimer , ஒன்றுபட்டது மாநிலங்களில் , மருந்து பாதுகாப்பு தகவல்தொடர்புகள் , பெட்டி எச்சரிக்கை ,